zirconium has been researched along with Neuroendocrine Tumors in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, R; Ashworth, A; Badura, ML; Bailis, JM; Bidkar, AP; Chan, E; Chou, J; Cooke, KS; Delafontaine, B; Egusa, EA; Feng, FY; Flavell, RR; Hashemi Sadraei, N; Huang, J; Lee, F; Robinson, TM; Rottey, S; Salvati, M; Shenoy, T; Small, EJ; Steri, V; Stohr, BA; Trepka, K; Wang, S; Wang, Y; Yu, B; Zhu, J | 1 |
Bongaerts, AH; Brouwers, AH; de Jong, JR; de Vries, EG; Fiebrich, HB; Links, TP; Lub-de Hooge, MN; Oosting, SF; Oude Munnink, TH; Sluiter, WJ; van Asselt, SJ; Walenkamp, AM | 1 |
Abou, DS; Beattie, BJ; Carlin, SD; Lewis, JS; Pinkse, MW; Ramos, NN; Thorek, DL; Wolterbeek, HT | 1 |
3 other study(ies) available for zirconium and Neuroendocrine Tumors
Article | Year |
---|---|
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.
Topics: Animals; Antibodies, Monoclonal; Humans; Immunotherapy; Intracellular Signaling Peptides and Proteins; Ligands; Male; Membrane Proteins; Mice; Neuroendocrine Tumors; Positron-Emission Tomography; Prostatic Neoplasms; Zirconium | 2023 |
Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Transport; Chromogranin A; Everolimus; Feasibility Studies; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radioisotopes; Sirolimus; Treatment Outcome; Vascular Endothelial Growth Factor A; Zirconium | 2014 |
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.
Topics: Animals; Cell Line, Tumor; Contrast Media; Gadolinium; Humans; Isotopes; Liposomes; Magnetic Resonance Imaging; Mice; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Receptors, Somatostatin; Zirconium | 2013 |